Institutional Ownership Travere Therapeutics, Inc. (TVTX)
This table provides information about the institutional ownership of Travere Therapeutics, Inc. (TVTX). We have compiled data on the 214 institutions that hold shares in the stock, with a total of 94.3 Million shares, which have been reported (via 13F filing form) to have a value of $1.71 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,644,789
shares
|
$137 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.95%
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
7,358,000
shares
|
$131 Million
1.81% of portfolio
|
Q4 2024
Reduced 3.79%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
6,742,165
shares
|
$120 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.32%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
4,973,649
shares
|
$88.9 Million
3.46% of portfolio
|
Q4 2024
Added 6.17%
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
4,259,557
shares
|
$76.1 Million
0.09% of portfolio
|
Q4 2024
Reduced 0.31%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
4,058,632
shares
|
$72.5 Million
0.04% of portfolio
|
Q4 2024
Added 12657.78%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,767,235
shares
|
$67.3 Million
0.0% of portfolio
|
Q4 2024
Added 37.66%
|
|
Viking Global Investors LP
|
Feb 14, 2025 Q4 2024 |
2,901,925
shares
|
$51.9 Million
0.17% of portfolio
|
Q4 2024
New holding
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
2,409,514
shares
|
$43.1 Million
0.07% of portfolio
|
Q4 2024
Added 28.51%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
2,278,375
shares
|
$40.7 Million
0.03% of portfolio
|
Q4 2024
Added 23.82%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
2,217,975
shares
|
$39.6 Million
0.38% of portfolio
|
Q4 2024
Added 608.07%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
2,174,213
shares
|
$38.9 Million
0.15% of portfolio
|
Q4 2024
Added 36.71%
|
|
Emerald Advisers, LLC
|
Feb 11, 2025 Q4 2024 |
2,125,744
shares
|
$38 Million
1.57% of portfolio
|
Q4 2024
Added 8.42%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,114,056
shares
|
$37.8 Million
0.27% of portfolio
|
Q4 2024
Reduced 51.29%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,957,120
shares
|
$35 Million
0.04% of portfolio
|
Q2 2023
Added 26.22%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,842,301
shares
|
$32.9 Million
0.0% of portfolio
|
Q4 2024
Added 6.43%
|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
1,802,750
shares
|
$32.2 Million
1.99% of portfolio
|
Q4 2024
Added 31.44%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,743,190
shares
|
$31.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 4.85%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,650,603
shares
|
$29.5 Million
0.0% of portfolio
|
Q4 2024
Added 22.32%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
1,331,388
shares
|
$23.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 22.35%
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,150,000
shares
|
$20.6 Million
0.32% of portfolio
|
Q4 2024
New holding
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
1,117,792
shares
|
$20 Million
2.83% of portfolio
|
Q4 2024
Added 2.92%
|
|
Emerald Mutual Fund Advisers Trust
|
Feb 14, 2025 Q4 2024 |
1,101,774
shares
|
$19.7 Million
1.32% of portfolio
|
Q4 2024
Reduced 7.08%
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Feb 14, 2025 Q4 2024 |
1,007,197
shares
|
$18 Million
0.07% of portfolio
|
Q4 2024
Added 33.62%
|
|
Logos Global Management LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$17.9 Million
2.29% of portfolio
|
Q4 2024
Reduced 9.09%
|